New personalised therapies for lung cancer
4 Jun 2017
New personalised therapies for lung cancer
Selumetinib in children with recurrent or refractory low-grade glioma
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy
No link between pregnancy and breast cancer relapse
Hypogonadism following cisplatin treatment of testicular cancer
Recent childhood cancer survivors face less chronic disease risk than previous decades
Steady decrease in severe health problems for childhood cancer survivors
Editor's Choice for May 2017
Theory and application of electrochemotherapy
Intralesional T-VEC and combinations for melanoma
Duration of checkpoint inhibitor therapy
Deregulated TGF-β superfamily signalling in cancer